These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 28058461)

  • 1. PET brain imaging in HIV-associated neurocognitive disorders (HAND) in the era of combination antiretroviral therapy.
    Vera JH; Ridha B; Gilleece Y; Amlani A; Thorburn P; Dizdarevic S
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):895-902. PubMed ID: 28058461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain PET Imaging: Value for Understanding the Pathophysiology of HIV-associated Neurocognitive Disorder (HAND).
    Sinharay S; Hammoud DA
    Curr HIV/AIDS Rep; 2019 Feb; 16(1):66-75. PubMed ID: 30778853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dementia and neurocognitive disorders due to HIV-1 infection.
    Ances BM; Ellis RJ
    Semin Neurol; 2007 Feb; 27(1):86-92. PubMed ID: 17226745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography imaging of peripheral benzodiazepine receptor binding in human immunodeficiency virus-infected subjects with and without cognitive impairment.
    Wiley CA; Lopresti BJ; Becker JT; Boada F; Lopez OL; Mellors J; Meltzer CC; Wisniewski SR; Mathis CA
    J Neurovirol; 2006 Aug; 12(4):262-71. PubMed ID: 16966217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional brain distribution of translocator protein using [(11)C]DPA-713 PET in individuals infected with HIV.
    Coughlin JM; Wang Y; Ma S; Yue C; Kim PK; Adams AV; Roosa HV; Gage KL; Stathis M; Rais R; Rojas C; McGlothan JL; Watkins CC; Sacktor N; Guilarte TR; Zhou Y; Sawa A; Slusher BS; Caffo B; Kassiou M; Endres CJ; Pomper MG
    J Neurovirol; 2014 Jun; 20(3):219-32. PubMed ID: 24567030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging studies of the HIV-infected brain.
    Chang L; Shukla DK
    Handb Clin Neurol; 2018; 152():229-264. PubMed ID: 29604980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropathology of HAND With Suppressive Antiretroviral Therapy: Encephalitis and Neurodegeneration Reconsidered.
    Gelman BB
    Curr HIV/AIDS Rep; 2015 Jun; 12(2):272-9. PubMed ID: 25860316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Imaging of Neuroinflammation in HIV.
    Boerwinkle A; Ances BM
    J Neuroimmune Pharmacol; 2019 Mar; 14(1):9-15. PubMed ID: 30515624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developments in Neuroprotection for HIV-Associated Neurocognitive Disorders (HAND).
    Kolson DL
    Curr HIV/AIDS Rep; 2022 Oct; 19(5):344-357. PubMed ID: 35867211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive Impairment and Persistent CNS Injury in Treated HIV.
    Chan P; Hellmuth J; Spudich S; Valcour V
    Curr HIV/AIDS Rep; 2016 Aug; 13(4):209-17. PubMed ID: 27188299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing clinical phenotypes of HIV-associated neurocognitive disorders.
    Sacktor N
    J Neurovirol; 2018 Apr; 24(2):141-145. PubMed ID: 28752495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV Neuropathogenesis in the Presence of a Disrupted Dopamine System.
    Nickoloff-Bybel EA; Calderon TM; Gaskill PJ; Berman JW
    J Neuroimmune Pharmacol; 2020 Dec; 15(4):729-742. PubMed ID: 32506353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary trends in HIV-associated neurocognitive disorders in Ghana.
    Sarfo FS; Kyem G; Asibey SO; Tagge R; Ovbiagele B
    Clin Neurol Neurosurg; 2021 Nov; 210():107003. PubMed ID: 34715557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The far-reaching HAND of cART: cART effects on astrocytes.
    Gonzalez H; Podany A; Al-Harthi L; Wallace J
    J Neuroimmune Pharmacol; 2021 Mar; 16(1):144-158. PubMed ID: 32147775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment.
    Chan P; Brew BJ
    Curr HIV/AIDS Rep; 2014 Sep; 11(3):317-24. PubMed ID: 24966139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening HIV-associated neurocognitive disorders (HAND) among HIV positive patients attending antiretroviral therapy in South Wollo, Ethiopia.
    Tsegaw M; Andargie G; Alem G; Tareke M
    J Psychiatr Res; 2017 Feb; 85():37-41. PubMed ID: 27821271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular neuroimaging of inflammation in HIV.
    Alagaratnam J; Winston A
    Clin Exp Immunol; 2022 Oct; 210(1):14-23. PubMed ID: 35020855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When do models of NeuroAIDS faithfully imitate "the real thing"?
    Gelman BB; Endsley J; Kolson D
    J Neurovirol; 2018 Apr; 24(2):146-155. PubMed ID: 29256039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Signatures of HIV-1 Envelope Associated with HIV-Associated Neurocognitive Disorders.
    Evering TH
    Curr HIV/AIDS Rep; 2018 Feb; 15(1):72-83. PubMed ID: 29460224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HIV 1-associated neurocognitive disorder: current epidemiology, pathogenesis, diagnosis and management].
    Eggers C;
    Nervenarzt; 2014 Oct; 85(10):1280-90. PubMed ID: 25292163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.